Dark Forest Capital Management LP Ionis Pharmaceuticals Inc Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $1,553 - $2,107	-49 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$29.88 - $37.04 $1,374 - $1,703	46 Added 1533.33%	49 $2,000
Q4 2021 Feb 11, 2022	SELL	$25.61 - $35.1 $8,579 - $11,758	-335 Reduced 99.11%	3 $0
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $32,600 - $39,414	-972 Reduced 74.2%	338 $11,000
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $45,247 - $61,897	1,310 New	1,310 $52,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.06B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.